CUTANEOUS DRUG REACTIONS IN HIV-INFECTED PATIENTS IN THE HAART ERA

被引：6
作者：
Blanes, M. [1 ]
Belinchon, I. [2 ]
Portilla, J. [3 ]
机构：
[1] Hosp Marina Baixa, Unidad Dermatol, Av Alcalde Jaume Botella Mayor 7, Alicante 03570, Spain
[2] Univ Alicante, Hosp Gen, Secc Dermatol, Alicante, Spain
[3] Univ Alicante, Hosp Gen, Unidad Enfermedades Infecciosas, Alicante, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2009年 / 100卷 / 04期
关键词：
HAART; HIV; cutaneous drug reactions;
D O I：
10.1016/S0001-7310(09)70819-1
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The introduction of highly active antiretroviral treatment (HAART) in 1996 radically changed the clinical course of human immunodeficiency virus (HIV) infection as it led to a dramatic reduction in mortality in these patients. However, these treatments have their limitations, including adverse effects, therapeutic failure, pharmacokinetic interactions, the development of resistance, and abnormal immune responses. In this article we review the current situation of cutaneous drug reactions in HIV-infected patients.
引用
收藏
页码：253 / 265
页数：13
相关论文
共 120 条
[81]  
Montero M, 2005, ENFERM INFEC MICR CL, V23, P247, DOI 10.1157/13073154
[82]   Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres [J].
Mouton, Y ;
Alfandari, S ;
Valette, M ;
Cartier, F ;
Dellamonica, P ;
Humbert, G ;
Lang, JM ;
Massip, P ;
Mechali, D ;
Leclercq, P ;
Modai, J ;
Portier, H .
AIDS, 1997, 11 (12) :F101-F105
[83]   SELECTIVE CUTANEOUS HYPERPIGMENTATION IN MICE FOLLOWING ZIDOVUDINE ADMINISTRATION [J].
OBUCH, ML ;
BAKER, G ;
ROTH, RI ;
YEN, TSB ;
LEVIN, J ;
BERGER, TG .
ARCHIVES OF DERMATOLOGY, 1992, 128 (04) :508-513
[84]   PAPULOERYTHRODERMA [J].
OFUJI, S ;
FURUKAWA, F ;
MIYACHI, Y ;
OHNO, S .
DERMATOLOGICA, 1984, 169 (03) :125-&
[85]   Skin rash associated with atazanavir: report of three cases [J].
Ouagari, Z ;
Tubiana, R ;
Mohand, HA ;
Dominguez, S ;
Duvivier, C ;
Bricaire, F ;
Katlama, C ;
Caumes, E .
AIDS, 2006, 20 (08) :1207-1208
[86]   Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].
Palella, FJ ;
Delaney, KM ;
Moorman, AC ;
Loveless, MO ;
Fuhrer, J ;
Satten, GA ;
Aschman, DJ ;
Holmberg, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860
[87]   NAIL PIGMENTATION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) [J].
PANWALKER, AP .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (06) :943-944
[88]   DIDANOSINE AS PROBABLE CAUSE OF STEVENS-JOHNSON SYNDROME [J].
PARNEIXSPAKE, A ;
BASTUJIGARIN, S ;
LEVY, Y ;
DUBREUILLEMAIRE, ML ;
ROUJEAU, JC .
LANCET, 1992, 340 (8823) :857-858
[89]   Sarcoidosis after highly active antiretroviral therapy in a patient with AIDS [J].
Pascual, JC ;
Belinchón, I ;
Silvestre, JF ;
Vergara, G ;
Blanes, M ;
Bañuls, J ;
Betlloch, I ;
Boix, V .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (02) :156-158
[90]   Efavirenz-induced skin eruption and successful desensitization [J].
Phillips, EJ ;
Kuriakose, B ;
Knowles, SR .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (03) :430-432
3456789101112